ZURA – zura bio limited - class a ordinary shares (US:NASDAQ)
Stock Stats
News
Zura Bio Limited (NASDAQ: ZURA) had its "neutral" rating re-affirmed by analysts at HC Wainwright. They now have a $5.00 price target on the stock.
Zura Bio Launches Global Phase 2 TibuSURE Study to Evaluate Tibulizumab in Adults With Systemic Sclerosis
Zura Bio Limited (NASDAQ: ZURA) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald.
Zura Bio to Present at the Piper Sandler 36th Annual Healthcare Conference
Zura Bio Limited (NASDAQ: ZURA) had its "neutral" rating re-affirmed by analysts at HC Wainwright. They now have a $5.00 price target on the stock.
Form SCHEDULE 13G/A Zura Bio Ltd Filed by: ADAR1 Capital Management, LLC
Form SCHEDULE 13G/A Zura Bio Ltd Filed by: RA CAPITAL MANAGEMENT, L.P.
Form SCHEDULE 13G/A Zura Bio Ltd Filed by: GREAT POINT PARTNERS LLC
Form 5 Zura Bio Ltd For: Dec 31 Filed by: Sidhu Someit
Form 5 Zura Bio Ltd For: Dec 31 Filed by: Badial Verender S.
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.